Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Explore effective wealth management for families to enhance your collective financial health and achieve shared financial goals.
19,633 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
As InMode lays out its 2026 plan, investors want clarity on growth engines, margins, and execution. This article brea...
Alpha (AMR) just reported Q1 2026 results, raising questions about growth and margins. This analysis breaks down the ...
A corporate treasury model pivots back to Bitcoin buying after a pause, adopting a clear buy-for-sell rule. This appr...
Solesence kicked off 2026 with a solid Q1 showing across core segments. This deep dive breaks down the numbers, what ...
Plug Power has captured attention as gross margins begin to improve after years of pressure. This article breaks down...
A niche tech stock tied to crypto and forecasting markets surged today, driven by fresh funding and upbeat sentiment ...
A major institutional move grabs attention as landmark investment partners cuts its stake in Howard Hughes Holdings. ...
So-Young's Q1 2026 results offer clues about growth momentum and profitability. This article breaks down the numbers,...
A focused AI tilt ETF called CHAT can outperform broad tech in some periods, but XLK’s lower fees often matter more f...
Weibo's Q1 2026 earnings transcript reveals a steady growth path with ad-driven strength and improving non-ad monetiz...
This guide dives into groupon (grpn) 2026 earnings, breaking down the first-quarter insights, revenue streams, and ke...